Revenue Guidance Revised as ATS Medical Seeks to Placate the FDA
Last week, word came from the FDA that ATS Medical would need to provide additional information and clarification to support its PMA for the ATS […]
Articles by Doug Cress
Should Hospital Emergency Rooms Adopt the Managerial Techniques Found at Starbucks?
According to researchers at the Cambridge Health Alliance and Harvard Medical School, the median wait time in hospital emergency rooms increased 36% from 1997 to […]
HemeScan: CombiMatrix and Clarient to Advance Personalized Therapies for Chronic Lymphotic Leukemia
More partnering news, this time from CombiMatrix and Clarient, who will market and sell a genomics-based cancer test called HemeScan. HemeScan was developed by CombiMatrix; […]
Blue Shield of California Sees the 308-nanometer Light
Blue Shield of California, a plan that covers more than three million people, has approved payment for mild to moderate psoriasis treatment using the PhotoMedex […]
A Filtration Collaboration: Delcath and Aethlon to Expand Cancer Treatment Options
Aethlon Medical and Delcath Systems have agreed to jointly research and develop a new filtration cartridge for use in Delcath’s percutaneous hepatic perfusion (“PHP”) system. […]
Healthcare Reform 2008 – Evolution or Revolution?
Event to be hosted by the Executive Council Tuesday, February 12, 2008 8:00AM – 11:00 AM Harvard Club of New York 27 West 44th Street […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of […]
[Video Profile] Interview with John Seaberg, CEO of NeoChord
This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum. NeoChord aims to […]
Bad Tasting Medicine a Thing of the Past?
While some might consider forcing down terrible-tasting cough syrup a right of passage, this childhood trauma may soon go the way of chicken pox. Aversive […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting […]